What Level of Hepatitis B Antibody Is Protective? | Zendy

Andrew Jack | Zendy; A. Hall | Zendy; N. Maine | Zendy; Maimuna Mendy | Zendy; H.C. Whittle | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

What Level of Hepatitis B Antibody Is Protective?

Author(s) -

Andrew Jack,

A. Hall,

N. Maine,

Maimuna Mendy,

H.C. Whittle

Publication year - 1999

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1086/314578

Subject(s) - carriage , medicine , antibody , vaccination , hepatitis b , immunology , hepatitis b vaccine , virology , hepatitis , hepatitis a , hepatitis a vaccine , hepatitis b virus , immunization , virus , hbsag , pathology

This study assessed the level of vaccine-induced hepatitis B surface antibody that is protective against hepatitis B infection and carriage in The Gambia. Sera from 700 of a cohort of 1041 children vaccinated against hepatitis B in infancy were serially tested for markers of hepatitis B until age 7 years. No absolute level of protection against infection was found, but all children who attained a peak antibody response to vaccination of >=10 IU/L were protected against carriage of hepatitis B surface antigen. Two-thirds of 45 infected children experienced brief infection (determined by loss of core antibody). This transient infection was likely related to surface antibody level. The data support the use of the peak antibody response as the best indicator of protection against carriage and suggest that most infections after vaccination are short-lived.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research